Browsing Tag
Ryaltris
7 posts
Glenmark Pharmaceuticals balances modest Q1 FY26 growth with innovation drive, global partnerships and robust pipeline ambitions
Glenmark’s Q1 FY26 results reveal modest growth but highlight strong specialty launches, AbbVie licensing deal, and a robust innovation pipeline.
RYALTRIS: Glenmark’s quiet blockbuster? A 45-market launch strategy explained
RYALTRIS is Glenmark’s global allergy brand launched in 45+ countries. Explore how it’s reshaping the firm’s branded strategy and global revenue mix.
Glenmark Pharmaceuticals posts 12.8% revenue rise in FY25, beats market estimates
Glenmark Pharma posts ₹13,894 Cr profit in FY25. Explore its global growth, R&D breakthroughs, and why ISB 2001 may define its biotech future.
Glenmark Pharmaceuticals posts strong Q3 FY2025 earnings as global expansion gains momentum
Glenmark Pharmaceuticals Limited has reported a strong financial performance for the third quarter of fiscal year 2025, driven…
Glenmark’s stunning Q1 performance: How the pharma powerhouse is dominating global markets
Glenmark Pharmaceuticals Limited (Glenmark) has announced impressive financial results for the first quarter of FY 2024-25, marked by…
Glenmark Pharmaceuticals reports Q4 FY2023-24 revenue of Rs 30.63bn
Glenmark Pharmaceuticals Limited, a research-led, global pharmaceutical company, today released its financial results for the fourth quarter ending…
Glenmark gets marketing approval for Ryaltris in 13 European countries
Glenmark Pharmaceuticals said that it has secured marketing approval for Ryaltris, a fixed-dose combination nasal spray, in 13…